Status:
UNKNOWN
Restrictive Versus Liberal Red Cell Transfusion Strategy in Orthopedic-Oncology Patients Undergoing Surgery - a Randomized Controlled Study
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Red Blood Cells Transfusion.
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The rationale for perioperative red blood cell (RBC) transfusion is based on the observation that anemia is an independent risk factor for morbidity and mortality after cardiac operations. However, tr...
Eligibility Criteria
Inclusion
- Consecutive ASA I-III patients, with preoperative hemoglobin 12 gr% or less scheduled for major orthopedic-oncology surgery (one that is expected to carry moderate to severe blood loss) at Tel Aviv Sourasky Medical Center will be included in the study.
Exclusion
- Patients will be excluded for any of the following reasons:
- an age of less than 18 years;
- inability to receive blood products;
- pregnancy;
- emergency procedures;
- hepatic dysfunction (total bilirubin value higher than 1.5 mg/d);
- end-stage renal disease (receiving chronic dialysis therapy);
- acute coronary syndrome, active heart or lung disease and refusal to consent.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01491308
Start Date
January 1 2012
Last Update
December 13 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel, 64239